Specificity rule discovery in HIV-1 protease cleavage site analysis

Computational Biology and Chemistry

Volumn 32, Issue 1, 2008, Pages 72-79

  Kim, Hyeoncheol ^a   Zhang, Yiying ^b   Heo, Yong Seok ^c   Oh, Heung Bum ^d   Chen, Su Shing ^b  

^a Korea University   (South Korea)

^b University of Florida   (United States)

^c Konkuk University   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

HIV 1 cleavage site prediction rule discovery

Indexed keywords

ENZYME KINETICS; FEATURE EXTRACTION; LEARNING SYSTEMS; NEURAL NETWORKS;

BLACK-BOX METHODS; HIV INHIBITORS; HIV-1 CLEAVAGE SITE PREDICTION RULE DISCOVERY; MACHINE LEARNING ALGORITHMS;

LEARNING ALGORITHMS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 37549048173     PISSN: 14769271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiolchem.2007.09.006     Document Type: Article

References (41)

1. Andrews R., Diederich J., and Tickle A.B. Survey and critique of techniques for extracting rules from trained artificial neural networks. Knowledge-Based Syst. 8 6 (1995) 373-389
2. Beck Z., Hervio L., Dawson P., Elder J., and Madison E. Identification of efficiently cleaved substrates for hiv-1 protease using a phage display library and use in inhibitor development. Virology 274 (2000) 391-401
3. Beck Z., Lin Y., and Elder J. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases. J. Virol. 75 (2001) 9458-9469
4. Beck Z., Morris G., and Elder J. Defining hiv-1 protease substrate selectivity. Curr. Drug Targets Infect. Disord. 2 (2002) 37-50
5. Boden D., and Markowitz M. Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob. Agents Chemother. 42 (1998) 2775-2783
6. Brik A., and Wong C. Hiv-1 protease: mechanism and drug discovery. Org. Biomol. Chem. 1 (2003) 5-14
7. Cai Y., and Chou K. Artificial neural network model for predicting HIV protease cleavage sites in protein. Adv. Eng. Softw. 29 (1998) 119-128
8. Cai Y.-D., Liu X., Xu X., and Chou K.-C. Support vector machines for predicting hiv protease cleavage sites in protein. J. Comput. Chem. 23 (2002) 267-274
9. Chen L., Perlina A., and Lee C. Positive selection detection in 40,000 human immunodeficiency virus (hiv) type 1 sequences automatically identifies drug resistance and positive fitness mutations in hiv protease and reverse transcriptase. J. Virol. 78 (2004) 3722-3732
10. Chou K.-C. Prediction of human immunodeficiency virus protease cleavage sites in proteins. Anal. Biochem. 233 (1996) 1-14
11. Crooks G., Hon G., Chandonia J., and Brenner S. Weblogo: a sequence logo generator. Genome Res. 14 (2004) 1188-1190
12. Dauber D., Ziermann R., Parkin N., Maly D., Mahrus S., Harris J., Ellman J., Petropoulos C., and Craik C. Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. J. Virol. 76 (2002) 1359-1368
13. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 30 (2004) 115-133
14. de Oliveira T., Engelbrecht S., van Rensburg E.J., Gordon M., Bishop K., zur Megede J., Barnett S.W., and Cassol S. Variability at human immunodeficiency virus type 1 subtype c protease cleavage sites: an indication of viral fitness?. J. Virol. 77 17 (2003) 9422-9430
15. Dougherty E.R. Feature-selection overfitting with small-sample classifier design. IEEE Intell. Syst. 20 6 (2005) 64-66
16. Feher A., Weber I., Bagossi P., Boross P., Mahalingam B., Louis J., Copeland T., Torshin I., Harrison R., and Toser J. Effect of sequence polymorphism and drug resistance on two hiv-1 gag processing sites. Eur. J. Biochem. 269 (2002) 4114-4120
17. Forman G. Feature selection: We've barely scratched the surface. IEEE Intell. Syst. 20 6 (2005) 74-76
18. Fu L. Rule generation from neural networks. IEEE Trans. Syst. Man Cybern. 24 8 (1994) 1114-1124
19. Han J., and Kamber M. Data Mining Concepts and Techniques (2001), Morgan Kaufmann
20. Hazebrouck S., Machtelinckx-Delmas V., Kupiec J., and Sonigo P. Local and spatial factors determining hiv-1 protease substrate recognition. Biochem. J. 358 (2001) 505-510
21. Kim H. Computationally efficient heuristics for if-then rule extraction from feed-forward neural networks. Lect. Notes Artif. Intell. (1967) 170-182
22. Kim H. Feed-forward neural networks based on self-extracted knowledge. Proceedings of the 6th International Conference on Computational Intelligence and Natural Computing (2003) 1520-1523
23. Narayanan A., Wu X., and Yang Z.R. Mining viral protease data to extract cleavage knowledge. Bioinformatics 18 Suppl. 1 (2002) S5-S13
24. Pettit S., Simsic J., Loeb D., Everitt L., Hutchison C., and Swanstrom R. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the p1 amino acid. J. Biol. Chem. 266 (1991) 14539-14547
25. Ridky T., Cameron C., Cameron J., Leis J., Copeland T., Wlodawer A., Weber I., and Harrison R. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J. Biol. Chem. 271 (1996) 4709-4717
26. Rognvaldsson T., and You L. Why neural networks should not be used for HIV-1 protease cleavage site prediction. Bioinformatics 20 11 (2004) 1702-1709
27. Schneider, T.D., Stephens, R.M., 1990. Sequence logos: a new way to display consensus sequences, Nucleic Acids Res. 18, 6097-6100. http://www.lecb.ncifcrf.gov/toms/paper/logopaper/.
28. Setino R. A penalty-function approach for pruning feedforward neural networks. Neural Comput. 9 (1997) 185-204
29. Setino R., and Liu H. Understanding neural networks via rule extraction. Proceedings of the 14th International Conference on Neural Networks, vol. 1 (1995) 480-485
30. Taha I.A., and Ghosh J. Symbolic interpretation of artificial neural networks. IEEE Trans. Knowledge Data Eng. 11 3 (1999) 443-463
31. Thompson T., Chou K., and Zheng C. Neural network prediction of the hiv-1 protease cleavage sites. J. Theor. Biol. 177 (1995) 369-379
32. Thomson R., Hodgman T.C., Yang Z.R., and Doyle A.K. Characterizing proteolytic cleavage site activity using bio-basis function neural networks. Bioinformatics 19 14 (2003) 1741-1747
33. Tozser J., Bagossi P., Weber I., Louis J., Copeland T., and Oroszlan S. Studies on the symmetry and sequence context dependence of the hiv-1 proteinase specificity. J. Biol. Chem. 272 (1997) 16807-16814
34. Tozser J., Blaha I., Copeland T., Wondrak E., and Oroszlan S. Comparison of the hiv-1 and hiv-2 proteinases using oligopeptide substrates representing cleavage sites in gag and gag-pol polyproteins. FEBS Lett. 281 (1991) 77-80
35. Tozser J., Zahuczky G., Bagossi P., Louis J., Copeland T., Oroszlan S., Harrison R., and Weber I. Comparison of the substrate specificity of the human t-cell leukemia virus and human immunodeficiency virus proteinases. Eur. J. Biochem. 267 (2000) 6287-6295
36. Wlodawer A., Miller M., Jaskolski M., Sathyanarayana B., Baldwin E., Weber I., Selk L., Clawson L., Schneider J., and Kent S. Conserved folding in retroviral proteases: crystal structure of a synthetic hiv-1 protease. Science 245 (1989) 616-621
37. Wu C., and McLarty J. Neural Networks and Genome Informatics, vol. 1 (2000), Elsevier
38. Xing E., Jordan M., and Karp R. Feature selection for high-dimensional genomic microarray data. Proceedings of the 15th International Conference on Machine Learning (2001) 601-608
39. Yang Z.R., and Chou K.-C. Bio-support vector machines for computational proteomics. Bioinformatics 20 5 (2004) 735-741
40. Yang Z.R., Dalby A., and Qiu J. Mining hiv protease cleavage data using genetic programming with a sum-product function. Bioinformatics 20 18 (2004) 3398-3405
41. You L., Garwicz D., and Rognvaldsson T. Comprehensive bioinformatic analysis of the specificity of human immunodeficiency virus type 1 protease. J. Virol. 79 19 (2005) 12477-12486